Lujing Shao

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Oral antibiotics promote triple-negative breast cancer progression by inducing gut microbiota dysbiosis and taurocholic acid accumulation.

Oral antibiotics promote triple-negative breast cancer progression by inducing gut microbiota dysbiosis and taurocholic acid accumulation.

Journal: Acta biochimica et biophysica Sinica
Published: May 13, 2026

Targeting the Vim-PGI2 Pathway Enhances CD8+ T Cell-Mediated Antitumor Immunity in Breast Cancer.

Targeting the Vim-PGI2 Pathway Enhances CD8+ T Cell-Mediated Antitumor Immunity in Breast Cancer.

Journal: Human mutation
Published: October 29, 2025

Diagnosis and Management of Fanconi Anemia.

Diagnosis and Management of Fanconi Anemia.

Journal: Journal of evidence-based medicine
Published: September 03, 2025

Vimentin Regulates Alternative Polyadenylation and mTOR Signaling via ARVCF to Promote B Cell Lymphoma Progression.

Vimentin Regulates Alternative Polyadenylation and mTOR Signaling via ARVCF to Promote B Cell Lymphoma Progression.

Journal: Human mutation
Published: July 22, 2025

ZNF526 drives tumor growth by enhancing SHMT1-dependent serine metabolism and antioxidant capability in TNBC.

ZNF526 drives tumor growth by enhancing SHMT1-dependent serine metabolism and antioxidant capability in TNBC.

Journal: Molecular cancer
Published: June 26, 2025

Dual-solvent-induced persistent nanoscale wet film for controllable two-dimensional molecular crystallization toward polarization-sensitive photodetectors.

Dual-solvent-induced persistent nanoscale wet film for controllable two-dimensional molecular crystallization toward polarization-sensitive photodetectors.

Journal: Science bulletin
Published: January 03, 2025

Exploring vimentin's role in breast cancer via PICK1 alternative polyadenylation and the miR-615-3p-PICK1 interaction.

Exploring vimentin's role in breast cancer via PICK1 alternative polyadenylation and the miR-615-3p-PICK1 interaction.

Journal: BioFactors (Oxford, England)
Published: September 29, 2024

Possible new mechanisms of primary drug resistance in NSCLC with EGFR mutation treated with Osimertinib.

Possible new mechanisms of primary drug resistance in NSCLC with EGFR mutation treated with Osimertinib.

Journal: IUBMB life
Published: September 15, 2024

Intestine-derived fibroblast growth factor 19 alleviates lipopolysaccharide-induced liver injury by regulating bile acid homeostasis and directly improving oxidative stress.

Intestine-derived fibroblast growth factor 19 alleviates lipopolysaccharide-induced liver injury by regulating bile acid homeostasis and directly improving oxidative stress.

Journal: Journal of intensive medicine
Published: January 14, 2024

A bioinformatic analysis found low expression and clinical significance of ATF4 in breast cancer.

A bioinformatic analysis found low expression and clinical significance of ATF4 in breast cancer.

Journal: Heliyon
Published: November 08, 2023

ATF4 knockdown in macrophage impairs glycolysis and mediates immune tolerance by targeting HK2 and HIF-1α ubiquitination in sepsis.

ATF4 knockdown in macrophage impairs glycolysis and mediates immune tolerance by targeting HK2 and HIF-1α ubiquitination in sepsis.

Journal: Clinical immunology (Orlando, Fla.)
Published: April 18, 2023

Activating transcription factor 4 protects mice against sepsis-induced intestinal injury by regulating gut-resident macrophages differentiation.

Activating transcription factor 4 protects mice against sepsis-induced intestinal injury by regulating gut-resident macrophages differentiation.

Journal: Chinese medical journal
Published: December 05, 2022
Showing 1-12 of 22

Last Updated: 09/26/2026